These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 6127911)
21. The role of bacterial adherence in the initiation of clinical pyelonephritis. Svenson SB; Kallenius G Adv Nephrol Necker Hosp; 1986; 15():245-57. PubMed ID: 2869651 [No Abstract] [Full Text] [Related]
22. [Effect of P fimbriae on pyuria and bacterial colonization of the human urinary tract]. Wullt B; Bergsten G; Samuelsson M; Svanborg C Urologe A; 2003 Feb; 42(2):233-7. PubMed ID: 12607092 [TBL] [Abstract][Full Text] [Related]
23. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections. Ha US; Cho YH Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471 [TBL] [Abstract][Full Text] [Related]
24. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853 [TBL] [Abstract][Full Text] [Related]
25. Do type 1 fimbriae promote inflammation in the human urinary tract? Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236 [TBL] [Abstract][Full Text] [Related]
26. Passive immunisation of neonatal lambs against infection with enteropathogenic Escherichia coli via colostrum of ewes immunised with crude and purified K99 pili. Altmann K; Mukkur TK Res Vet Sci; 1983 Sep; 35(2):234-9. PubMed ID: 6138826 [TBL] [Abstract][Full Text] [Related]
27. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney. Rice JC; Peng T; Spence JS; Wang HQ; Goldblum RM; Corthésy B; Nowicki BJ J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807 [TBL] [Abstract][Full Text] [Related]
28. [Passive immunization trials against the infection with E. coli 0101:K30 strain, pathogenic to newborn mice]. Kétyi I Zentralbl Bakteriol Orig; 1966 Jun; 200(2):235-41. PubMed ID: 4869921 [No Abstract] [Full Text] [Related]
29. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae. Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977 [TBL] [Abstract][Full Text] [Related]
31. Infant mouse model of E. coli diarrhoea: clinical protection induced by vaccination of the mothers. Duchet-Suchaux M Ann Rech Vet; 1983; 14(3):319-31. PubMed ID: 6362544 [TBL] [Abstract][Full Text] [Related]
32. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. O'Hanley P; Lark D; Falkow S; Schoolnik G J Clin Invest; 1985 Feb; 75(2):347-60. PubMed ID: 2857730 [TBL] [Abstract][Full Text] [Related]
33. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice. Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045 [TBL] [Abstract][Full Text] [Related]
34. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. Tseng CC; Huang JJ; Ko WC; Yan JJ; Wu JJ J Urol; 2001 Nov; 166(5):1643-6. PubMed ID: 11586193 [TBL] [Abstract][Full Text] [Related]